Clostridium difficile Toxin A Undergoes Clathrin-Independent, PACSIN2-Dependent Endocytosis

PLoS Pathogens

Volumn 12, Issue 12, 2016, Pages

  Chandrasekaran, Ramyavardhanee ^a   Kenworthy, Anne K ^a   Lacy, D Borden ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CELL SURFACE RECEPTOR; CLATHRIN; CLOSTRIDIUM DIFFICILE TOXIN A; GLUCOSYLTRANSFERASE; PACSIN2 PROTEIN; PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG; BACTERIAL TOXIN; ENTEROTOXIN; PACSIN2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; VIRULENCE FACTOR;

ANALYSIS OF VARIANCE; ARTICLE; CELL VIABILITY ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; EPITHELIUM CELL; FLUORESCENCE; GENE SILENCING; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLAMMATION; INTERNALIZATION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION (PROCESS); WESTERN BLOTTING; ANIMAL; CACO-2 CELL LINE; CLOSTRIDIUM INFECTION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; HEK293 CELL LINE; IMAGE PROCESSING; METABOLISM; MOUSE; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; PROTEIN TRANSPORT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BACTERIAL TOXINS; BLOTTING, WESTERN; CACO-2 CELLS; CLATHRIN; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENDOCYTOSIS; ENTEROTOXINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VIRULENCE FACTORS;

EID: 85007591265     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006070     Document Type: Article

References (85)

1. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA, The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;55(2):216–23. Epub 2012/04/12.
2. Kelly CP, LaMont JT, Clostridium difficile—more difficult than ever. The New England journal of medicine. 2008;359(18):1932–40. Epub 2008/10/31. doi: 10.1056/NEJMra070750018971494
3. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. The New England journal of medicine. 2015;372(9):825–34. Epub 2015/02/26. doi: 10.1056/NEJMoa140891325714160
4. Voth DE, Ballard JD, Clostridium difficile toxins: mechanism of action and role in disease. Clinical microbiology reviews. 2005;18(2):247–63. Epub 2005/04/16. PubMed Central PMCID: PMCPMC1082799. doi: 10.1128/CMR.18.2.247-263.200515831824
5. Carter GP, Chakravorty A, Pham Nguyen TA, Mileto S, Schreiber F, Li L, et al. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections. mBio. 2015;6(3):e00551. Epub 2015/06/04. PubMed Central PMCID: PMCPMC4453007. doi: 10.1128/mBio.00551-1526037121
6. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP, The role of toxin A and toxin B in Clostridium difficile infection. Nature. 2010;467(7316):711–3. Epub 2010/09/17. doi: 10.1038/nature0939720844489
7. Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP, Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. The Journal of infectious diseases. 2014;209(1):83–6. Epub 2013/08/13. PubMed Central PMCID: PMCPMC3864386. doi: 10.1093/infdis/jit42623935202
8. McDonald LC, Killgore GE, Thompson A, Owens RC, Jr.Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. The New England journal of medicine. 2005;353(23):2433–41. Epub 2005/12/03. doi: 10.1056/NEJMoa05159016322603
9. Rupnik M, Janezic S, An Update on Clostridium difficile Toxinotyping. Journal of clinical microbiology. 2016;54(1):13–8. Epub 2015/10/30. PubMed Central PMCID: PMCPMC4702747. doi: 10.1128/JCM.02083-1526511734
10. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K, Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature. 1995;375(6531):500–3. Epub 1995/06/08. doi: 10.1038/375500a07777059
11. Just I, Wilm M, Selzer J, Rex G, von Eichel-Streiber C, Mann M, et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. The Journal of biological chemistry. 1995;270(23):13932–6. Epub 1995/06/09. 7775453
12. Dingle T, Wee S, Mulvey GL, Greco A, Kitova EN, Sun J, et al. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology. 2008;18(9):698–706. Epub 2008/05/30. doi: 10.1093/glycob/cwn04818509107
13. Greco A, Ho JG, Lin SJ, Palcic MM, Rupnik M, Ng KK, Carbohydrate recognition by Clostridium difficile toxin A. Nature structural & molecular biology. 2006;13(5):460–1. Epub 2006/04/20.
14. von Eichel-Streiber C, Sauerborn M, Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene. 1990;96(1):107–13. Epub 1990/11/30. 2148295
15. Frey SM, Wilkins TD, Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infection and immunity. 1992;60(6):2488–92. Epub 1992/06/01. PubMed Central PMCID: PMCPMC257186. 1375199
16. Orth P, Xiao L, Hernandez LD, Reichert P, Sheth PR, Beaumont M, et al. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography. The Journal of biological chemistry. 2014;289(26):18008–21. Epub 2014/05/14. PubMed Central PMCID: PMCPMC4140266. doi: 10.1074/jbc.M114.56074824821719
17. Sauerborn M, Leukel P, von Eichel-Streiber C, The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS microbiology letters. 1997;155(1):45–54. Epub 1997/11/05. 9345763
18. Genisyuerek S, Papatheodorou P, Guttenberg G, Schubert R, Benz R, Aktories K, Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B. Molecular microbiology. 2011;79(6):1643–54. Epub 2011/01/15. doi: 10.1111/j.1365-2958.2011.07549.x21231971
19. LaFrance ME, Farrow MA, Chandrasekaran R, Sheng J, Rubin DH, Lacy DB, Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 2015;112(22):7073–8. Epub 2015/06/04. PubMed Central PMCID: PMCPMC4460460. doi: 10.1073/pnas.150079111226038560
20. Manse JS, Baldwin MR, Binding and entry of Clostridium difficile toxin B is mediated by multiple domains. FEBS letters. 2015;589(24 Pt B):3945–51. Epub 2015/11/26.
21. Olling A, Goy S, Hoffmann F, Tatge H, Just I, Gerhard R, The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A. PloS one. 2011;6(3):e17623. Epub 2011/03/30. PubMed Central PMCID: PMCPMC3060812. doi: 10.1371/journal.pone.001762321445253
22. Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, Aktories K, Low pH-induced formation of ion channels by clostridium difficile toxin B in target cells. The Journal of biological chemistry. 2001;276(14):10670–6. Epub 2001/01/21. doi: 10.1074/jbc.M00944520011152463
23. Qa'Dan M, Spyres LM, Ballard JD, pH-induced conformational changes in Clostridium difficile toxin B. Infection and immunity. 2000;68(5):2470–4. Epub 2000/04/18. PubMed Central PMCID: PMCPMC97448. 10768933
24. Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, Schrattenholz A, et al. Autocatalytic cleavage of Clostridium difficile toxin B. Nature. 2007;446(7134):415–9. Epub 2007/03/06. doi: 10.1038/nature0562217334356
25. Carneiro BA, Fujii J, Brito GA, Alcantara C, Oria RB, Lima AA, et al. Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infection and immunity. 2006;74(1):81–7. Epub 2005/12/22. PubMed Central PMCID: PMCPMC1346681. doi: 10.1128/IAI.74.1.81-87.200616368960
26. Fiorentini C, Fabbri A, Falzano L, Fattorossi A, Matarrese P, Rivabene R, et al. Clostridium difficile toxin B induces apoptosis in intestinal cultured cells. Infection and immunity. 1998;66(6):2660–5. Epub 1998/05/29. PubMed Central PMCID: PMCPMC108253. 9596731
27. Gerhard R, Nottrott S, Schoentaube J, Tatge H, Olling A, Just I, Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. Journal of medical microbiology. 2008;57(Pt 6):765–70. Epub 2008/05/16. doi: 10.1099/jmm.0.47769-018480335
28. Qa'Dan M, Ramsey M, Daniel J, Spyres LM, Safiejko-Mroczka B, Ortiz-Leduc W, et al. Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells. Cellular microbiology. 2002;4(7):425–34. Epub 2002/07/10. 12102688
29. Chumbler NM, Farrow MA, Lapierre LA, Franklin JL, Haslam DB, Goldenring JR, et al. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS pathogens. 2012;8(12):e1003072. Epub 2012/12/14. PubMed Central PMCID: PMCPMC3516567. doi: 10.1371/journal.ppat.100307223236283
30. Farrow MA, Chumbler NM, Lapierre LA, Franklin JL, Rutherford SA, Goldenring JR, et al. Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(46):18674–9. Epub 2013/10/30. doi: 10.1073/pnas.131365811024167244
31. Krivan HC, Clark GF, Smith DF, Wilkins TD, Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infection and immunity. 1986;53(3):573–81. Epub 1986/09/01. PubMed Central PMCID: PMCPMC260829. 3744552
32. Na X, Kim H, Moyer MP, Pothoulakis C, LaMont JT, gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infection and immunity. 2008;76(7):2862–71. Epub 2008/04/16. PubMed Central PMCID: PMCPMC2446715. doi: 10.1128/IAI.00326-0818411291
33. Pothoulakis C, Gilbert RJ, Cladaras C, Castagliuolo I, Semenza G, Hitti Y, et al. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. The Journal of clinical investigation. 1996;98(3):641–9. Epub 1996/08/01. PubMed Central PMCID: PMCPMC507473. doi: 10.1172/JCI1188358698855
34. Tao L, Zhang J, Meraner P, Tovaglieri A, Wu X, Gerhard R, et al. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature. 2016;538(7625):350–5. Epub 2016/10/21. doi: 10.1038/nature1979927680706
35. Yuan P, Zhang H, Cai C, Zhu S, Zhou Y, Yang X, et al. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell research. 2015;25(2):157–68. Epub 2014/12/31. PubMed Central PMCID: PMCPMC4650570. doi: 10.1038/cr.2014.16925547119
36. Papatheodorou P, Zamboglou C, Genisyuerek S, Guttenberg G, Aktories K, Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PloS one. 2010;5(5):e10673. Epub 2010/05/26. PubMed Central PMCID: PMCPMC2871790. doi: 10.1371/journal.pone.001067320498856
37. Gerhard R, Frenzel E, Goy S, Olling A, Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain. Journal of medical microbiology. 2013. Epub 2013/04/06.
38. Doherty GJ, McMahon HT, Mechanisms of endocytosis. Annual review of biochemistry. 2009;78:857–902. Epub 2009/03/26. doi: 10.1146/annurev.biochem.78.081307.11054019317650
39. Mayor S, Pagano RE, Pathways of clathrin-independent endocytosis. Nature reviews Molecular cell biology. 2007;8(8):603–12. Epub 2007/07/05. doi: 10.1038/nrm221617609668
40. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T, Dynasore, a cell-permeable inhibitor of dynamin. Developmental cell. 2006;10(6):839–50. Epub 2006/06/03. doi: 10.1016/j.devcel.2006.04.00216740485
41. Boucrot E, Ferreira AP, Almeida-Souza L, Debard S, Vallis Y, Howard G, et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature. 2015;517(7535):460–5. Epub 2014/12/18. doi: 10.1038/nature1406725517094
42. Renard HF, Simunovic M, Lemiere J, Boucrot E, Garcia-Castillo MD, Arumugam S, et al. Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis. Nature. 2015;517(7535):493–6. Epub 2014/12/18. PubMed Central PMCID: PMCPMC4342003. doi: 10.1038/nature1406425517096
43. Parton RG, Simons K, The multiple faces of caveolae. Nature reviews Molecular cell biology. 2007;8(3):185–94. Epub 2007/02/24. doi: 10.1038/nrm212217318224
44. Field FJ, Born E, Murthy S, Mathur SN, Caveolin is present in intestinal cells: role in cholesterol trafficking?Journal of lipid research. 1998;39(10):1938–50. Epub 1998/10/27. 9788240
45. Mirre C, Monlauzeur L, Garcia M, Delgrossi MH, Le Bivic A, Detergent-resistant membrane microdomains from Caco-2 cells do not contain caveolin. The American journal of physiology. 1996;271(3 Pt 1):C887–94. Epub 1996/09/01.
46. Vogel U, Sandvig K, van Deurs B, Expression of caveolin-1 and polarized formation of invaginated caveolae in Caco-2 and MDCK II cells. Journal of cell science. 1998;111 (Pt 6):825–32. Epub 1998/05/12.
47. Fujimoto T, Kogo H, Nomura R, Une T, Isoforms of caveolin-1 and caveolar structure. Journal of cell science. 2000;113Pt 19:3509–17. Epub 2000/09/14.
48. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (New York, NY). 2001;293(5539):2449–52. Epub 2001/08/11.
49. Hansen CG, Howard G, Nichols BJ, Pacsin 2 is recruited to caveolae and functions in caveolar biogenesis. Journal of cell science. 2011;124(Pt 16):2777–85. Epub 2011/08/03. doi: 10.1242/jcs.08431921807942
50. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008;132(1):113–24. Epub 2008/01/15. PubMed Central PMCID: PMCPMC2265257. doi: 10.1016/j.cell.2007.11.04218191225
51. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG, Caveolin, a protein component of caveolae membrane coats. Cell. 1992;68(4):673–82. Epub 1992/02/21. 1739974
52. Senju Y, Itoh Y, Takano K, Hamada S, Suetsugu S, Essential role of PACSIN2/syndapin-II in caveolae membrane sculpting. Journal of cell science. 2011;124(Pt 12):2032–40. Epub 2011/05/26. doi: 10.1242/jcs.08626421610094
53. Wang Q, Navarro MV, Peng G, Molinelli E, Goh SL, Judson BL, et al. Molecular mechanism of membrane constriction and tubulation mediated by the F-BAR protein Pacsin/Syndapin. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(31):12700–5. Epub 2009/06/25. PubMed Central PMCID: PMCPMC2722316. doi: 10.1073/pnas.090297410619549836
54. Qualmann B, Kelly RB, Syndapin isoforms participate in receptor-mediated endocytosis and actin organization. The Journal of cell biology. 2000;148(5):1047–62. Epub 2000/03/08. PubMed Central PMCID: PMCPMC2174535. 10704453
55. Kessels MM, Qualmann B, The syndapin protein family: linking membrane trafficking with the cytoskeleton. Journal of cell science. 2004;117(Pt 15):3077–86. Epub 2004/07/01. doi: 10.1242/jcs.0129015226389
56. de Kreuk BJ, Nethe M, Fernandez-Borja M, Anthony EC, Hensbergen PJ, Deelder AM, et al. The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration. Journal of cell science. 2011;124(Pt 14):2375–88. Epub 2011/06/23. doi: 10.1242/jcs.08063021693584
57. Modi N, Gulati N, Solomon K, Monaghan T, Robins A, Sewell HF, et al. Differential binding and internalization of Clostridium difficile toxin A by human peripheral blood monocytes, neutrophils and lymphocytes. Scandinavian journal of immunology. 2011;74(3):264–71. Epub 2011/05/21. doi: 10.1111/j.1365-3083.2011.02578.x21595735
58. Florin I, Thelestam M, Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microbial pathogenesis. 1986;1(4):373–85. Epub 1986/08/01. 3508493
59. Schelhaas M, Shah B, Holzer M, Blattmann P, Kuhling L, Day PM, et al. Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS pathogens. 2012;8(4):e1002657. Epub 2012/04/27. PubMed Central PMCID: PMCPMC3334892. doi: 10.1371/journal.ppat.100265722536154
60. Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, De Smedt SC, et al. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Molecular therapy: the journal of the American Society of Gene Therapy. 2010;18(3):561–9. Epub 2009/12/17. PubMed Central PMCID: PMCPMC2839427.
61. Watanabe S, Hirose M, Miyazaki A, Tomono M, Takeuchi M, Kitamura T, et al. Calmodulin antagonists inhibit the phagocytic activity of cultured Kupffer cells. Laboratory investigation; a journal of technical methods and pathology. 1988;59(2):214–8. Epub 1988/08/01. 3404973
62. Howes MT, Mayor S, Parton RG, Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis. Current opinion in cell biology. 2010;22(4):519–27. Epub 2010/05/05. doi: 10.1016/j.ceb.2010.04.00120439156
63. Sandvig K, Pust S, Skotland T, van Deurs B, Clathrin-independent endocytosis: mechanisms and function. Current opinion in cell biology. 2011;23(4):413–20. Epub 2011/04/07. doi: 10.1016/j.ceb.2011.03.00721466956
64. Fra AM, Williamson E, Simons K, Parton RG, De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(19):8655–9. Epub 1995/09/12. PubMed Central PMCID: PMCPMC41025. 7567992
65. Chaudhary N, Gomez GA, Howes MT, Lo HP, McMahon KA, Rae JA, et al. Endocytic crosstalk: cavins, caveolins, and caveolae regulate clathrin-independent endocytosis. PLoS biology. 2014;12(4):e1001832. Epub 2014/04/10. PubMed Central PMCID: PMCPMC3979662. doi: 10.1371/journal.pbio.100183224714042
66. Lajoie P, Kojic LD, Nim S, Li L, Dennis JW, Nabi IR, Caveolin-1 regulation of dynamin-dependent, raft-mediated endocytosis of cholera toxin-B sub-unit occurs independently of caveolae. Journal of cellular and molecular medicine. 2009;13(9b):3218–25. Epub 2009/05/15. PubMed Central PMCID: PMCPMC4516479. doi: 10.1111/j.1582-4934.2009.00732.x19438805
67. Fielding PE, Fielding CJ, Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry. 1995;34(44):14288–92. Epub 1995/11/07. 7578031
68. Frank PG, Cheung MW, Pavlides S, Llaverias G, Park DS, Lisanti MP, Caveolin-1 and regulation of cellular cholesterol homeostasis. American journal of physiology Heart and circulatory physiology. 2006;291(2):H677–86. Epub 2006/04/11. doi: 10.1152/ajpheart.01092.200516603689
69. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K, VIP21/caveolin is a cholesterol-binding protein. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(22):10339–43. Epub 1995/10/24. PubMed Central PMCID: PMCPMC40792. 7479780
70. Giesemann T, Jank T, Gerhard R, Maier E, Just I, Benz R, et al. Cholesterol-dependent pore formation of Clostridium difficile toxin A. The Journal of biological chemistry. 2006;281(16):10808–15. Epub 2006/03/04. doi: 10.1074/jbc.M51272020016513641
71. Itoh T, Erdmann KS, Roux A, Habermann B, Werner H, De Camilli P, Dynamin and the actin cytoskeleton cooperatively regulate plasma membrane invagination by BAR and F-BAR proteins. Developmental cell. 2005;9(6):791–804. Epub 2005/12/06. doi: 10.1016/j.devcel.2005.11.00516326391
72. Kostan J, Salzer U, Orlova A, Toro I, Hodnik V, Senju Y, et al. Direct interaction of actin filaments with F-BAR protein pacsin2. EMBO reports. 2014;15(11):1154–62. Epub 2014/09/14. PubMed Central PMCID: PMCPMC4253489. doi: 10.15252/embr.20143926725216944
73. Modregger J, Ritter B, Witter B, Paulsson M, Plomann M, All three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis. Journal of cell science. 2000;113Pt 24:4511–21. Epub 2000/11/18.
74. Qualmann B, Roos J, DiGregorio PJ, Kelly RB, Syndapin I, a synaptic dynamin-binding protein that associates with the neural Wiskott-Aldrich syndrome protein. Molecular biology of the cell. 1999;10(2):501–13. Epub 1999/02/09. PubMed Central PMCID: PMCPMC25183. 9950691
75. Shimada A, Takano K, Shirouzu M, Hanawa-Suetsugu K, Terada T, Toyooka K, et al. Mapping of the basic amino-acid residues responsible for tubulation and cellular protrusion by the EFC/F-BAR domain of pacsin2/Syndapin II. FEBS letters. 2010;584(6):1111–8. Epub 2010/03/02. doi: 10.1016/j.febslet.2010.02.05820188097
76. Plomann M, Lange R, Vopper G, Cremer H, Heinlein UA, Scheff S, et al. PACSIN, a brain protein that is upregulated upon differentiation into neuronal cells. European journal of biochemistry / FEBS. 1998;256(1):201–11. Epub 1998/09/24.
77. Ritter B, Modregger J, Paulsson M, Plomann M, PACSIN 2, a novel member of the PACSIN family of cytoplasmic adapter proteins. FEBS letters. 1999;454(3):356–62. Epub 1999/08/04. 10431838
78. Kessels MM, Qualmann B, Syndapin oligomers interconnect the machineries for endocytic vesicle formation and actin polymerization. The Journal of biological chemistry. 2006;281(19):13285–99. Epub 2006/03/17. doi: 10.1074/jbc.M51022620016540475
79. de Kreuk BJ, Anthony EC, Geerts D, Hordijk PL, The F-BAR protein PACSIN2 regulates epidermal growth factor receptor internalization. The Journal of biological chemistry. 2012;287(52):43438–53. Epub 2012/11/07. PubMed Central PMCID: PMCPMC3527931. doi: 10.1074/jbc.M112.39107823129763
80. Aktories K, Bacterial toxins that target Rho proteins. The Journal of clinical investigation. 1997;99(5):827–9. Epub 1997/03/01. PubMed Central PMCID: PMCPMC507888. doi: 10.1172/JCI1192459062338
81. Donta ST, Sullivan N, Wilkins TD, Differential effects of Clostridium difficile toxins on tissue-cultured cells. Journal of clinical microbiology. 1982;15(6):1157–8. Epub 1982/06/01. PubMed Central PMCID: PMCPMC272271. 7107845
82. Meinecke M, Boucrot E, Camdere G, Hon WC, Mittal R, McMahon HT, Cooperative recruitment of dynamin and BIN/amphiphysin/Rvs (BAR) domain-containing proteins leads to GTP-dependent membrane scission. The Journal of biological chemistry. 2013;288(9):6651–61. Epub 2013/01/09. PubMed Central PMCID: PMCPMC3585104. doi: 10.1074/jbc.M112.44486923297414
83. Kirchhausen T, Macia E, Pelish HE, Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods in enzymology. 2008;438:77–93. Epub 2008/04/17. PubMed Central PMCID: PMCPMC2796620. doi: 10.1016/S0076-6879(07)38006-318413242
84. Pruitt RN, Chumbler NM, Rutherford SA, Farrow MA, Friedman DB, Spiller B, et al. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. The Journal of biological chemistry. 2012;287(11):8013–20. Epub 2012/01/24. PubMed Central PMCID: PMCPMC3318759. doi: 10.1074/jbc.M111.29841422267739
85. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature methods. 2012;9(7):676–82. Epub 2012/06/30. PubMed Central PMCID: PMCPMC3855844. doi: 10.1038/nmeth.201922743772